目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.2.1. RESEARCH OBJECTIVE
2.2.2. ASSUMPTIONS
2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY
3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING MODALITY
3.6. MARKET SIZE ESTIMATION
3.6.1. BOTTOM-UP APPROACH
3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION

4. MARKET DYNAMICS
4.1. OVERVIEW
4.2. DRIVERS
4.3. RESTRAINTS
4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS
5.1. VALUE CHAIN ANALYSIS
5.2. PORTER’S FIVE FORCES ANALYSIS
5.2.1. BARGAINING POWER OF SUPPLIERS
5.2.2. BARGAINING POWER OF BUYERS
5.2.3. THREAT OF NEW ENTRANTS
5.2.4. THREAT OF SUBSTITUTES
5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
5.3.1. IMPACT ON DEMAND
5.3.2. IMPACT ON PRICING
5.3.3. IMPACT ON KEY PLAYERS

6. GLOBAL MICRONEEDLING MARKET, BY PROCEDURE
6.1. OVERVIEW
6.2. RF MICRONEEDLING
6.3. TRADITIONAL MICRONEEDLING
6.4. PRP MICRONEEDLING

7. GLOBAL MICRONEEDLING MARKET, BY PRODUCT
7.1. OVERVIEW
7.2. DERMA-STAMP
7.3. DERMAPEN
7.4. DERMAROLLERS
7.5. RF MICRONEEDLING DEVICES
7.6. OTHERS

8. GLOBAL MICRONEEDLING MARKET, BY NEEDLE MATERIAL
8.1. OVERVIEW
8.2. SILICON
8.3. METAL
8.4. GLASS
8.5. OTHERS

9. GLOBAL MICRONEEDLING MARKET, BY APPLICATION
9.1. OVERVIEW
9.2. SKIN REJUVENATION
9.3. ACNE SCARS
9.4. TRAUMATIC & SURGICAL SCARS
9.5. OTHERS

10. GLOBAL MICRONEEDLING MARKET, BY END USER
10.1. OVERVIEW
10.2. HOSPITALS
10.3. DERMATOLOGY CLINICS
10.4. HOMECARE SETTINGS
10.5. OTHERS

11. GLOBAL MICRONEEDLING MARKET, BY REGION
11.1. OVERVIEW
11.1. NORTH AMERICA
11.1.1. US
11.1.2. CANADA
11.2. EUROPE
11.2.1. GERMANY
11.2.2. FRANCE
11.2.3. UK
11.2.4. ITALY
11.2.5. SPAIN
11.2.6. REST OF EUROPE
11.3. ASIA-PACIFIC
11.3.1. CHINA
11.3.2. INDIA
11.3.3. JAPAN
11.3.4. SOUTH KOREA
11.3.5. AUSTRALIA
11.3.6. REST OF ASIA-PACIFIC
11.4. REST OF THE WORLD
11.4.1. MIDDLE EAST
11.4.2. AFRICA
11.4.3. LATIN AMERICA

12. COMPETITIVE LANDSCAPE
12.1. OVERVIEW
12.2. COMPETITIVE ANALYSIS
12.3. MARKET SHARE ANALYSIS
12.4. MAJOR GROWTH STRATEGY IN THE GLOBAL MICRONEEDLING MARKET,
12.5. COMPETITIVE BENCHMARKING
12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICRONEEDLING MARKET,
12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
12.7.2. MERGER & ACQUISITIONS
12.7.3. JOINT VENTURES
12.8. MAJOR PLAYERS FINANCIAL MATRIX
12.8.1. SALES & OPERATING INCOME, 2022
12.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2022

13. COMPANY PROFILES
13.1. CROWN AESTHETICS
13.1.1. COMPANY OVERVIEW
13.1.2. FINANCIAL OVERVIEW
13.1.3. PRODUCTS OFFERED
13.1.4. KEY DEVELOPMENTS
13.1.5. SWOT ANALYSIS
13.1.6. KEY STRATEGIES
13.2. LUMENIS BE LTD
13.2.1. COMPANY OVERVIEW
13.2.2. FINANCIAL OVERVIEW
13.2.3. PRODUCTS OFFERED
13.2.4. KEY DEVELOPMENTS
13.2.5. SWOT ANALYSIS
13.2.6. KEY STRATEGIES
13.3. AESTHETICS BIOMEDICAL
13.3.1. COMPANY OVERVIEW
13.3.2. FINANCIAL OVERVIEW
13.3.3. PRODUCTS OFFERED
13.3.4. KEY DEVELOPMENTS
13.3.5. SWOT ANALYSIS
13.3.6. KEY STRATEGIES
13.4. INMODE
13.4.1. COMPANY OVERVIEW
13.4.2. FINANCIAL OVERVIEW
13.4.3. PRODUCTS OFFERED
13.4.4. KEY DEVELOPMENTS
13.4.5. SWOT ANALYSIS
13.4.6. KEY STRATEGIES
13.5. LUTRONIC
13.5.1. COMPANY OVERVIEW
13.5.2. FINANCIAL OVERVIEW
13.5.3. PRODUCTS OFFERED
13.5.4. KEY DEVELOPMENTS
13.5.5. SWOT ANALYSIS
13.5.6. KEY STRATEGIES
13.6. CYNOSURE
13.6.1. COMPANY OVERVIEW
13.6.2. FINANCIAL OVERVIEW
13.6.3. PRODUCTS OFFERED
13.6.4. KEY DEVELOPMENTS
13.6.5. SWOT ANALYSIS
13.6.6. KEY STRATEGIES
13.7. CUTERA
13.7.1. COMPANY OVERVIEW
13.7.2. FINANCIAL OVERVIEW
13.7.3. PRODUCTS OFFERED
13.7.4. KEY DEVELOPMENTS
13.7.5. SWOT ANALYSIS
13.7.6. KEY STRATEGIES
13.8. ENDYMED
13.8.1. COMPANY OVERVIEW
13.8.2. FINANCIAL OVERVIEW
13.8.3. PRODUCTS OFFERED
13.8.4. KEY DEVELOPMENTS
13.8.5. SWOT ANALYSIS
13.8.6. KEY STRATEGIES
13.9. CANDELA CORPORATION
13.9.1. COMPANY OVERVIEW
13.9.2. FINANCIAL OVERVIEW
13.9.3. PRODUCTS OFFERED
13.9.4. KEY DEVELOPMENTS
13.9.5. SWOT ANALYSIS
13.9.6. KEY STRATEGIES
13.10. DERMAROLLER GMBH
13.10.1. COMPANY OVERVIEW
13.10.2. FINANCIAL OVERVIEW
13.10.3. PRODUCTS OFFERED
13.10.4. KEY DEVELOPMENTS
13.10.5. SWOT ANALYSIS
13.10.6. KEY STRATEGIES

14. APPENDIX
14.1. REFERENCES
14.2. RELATED REPORTS